Sandoz (OTCQX:SDZNY) Monday mentioned that Pyzchiva (ustekinumab-ttwe) is now commercially accessible to sufferers throughout the U.S.
Developed by Samsung Bioepis Co., and commercialized by Sandoz, Pyzchiva has been accredited by the U.S. Meals and Drug Administration for the remedy of sure power inflammatory
